Maria C Albareda
Overview
Explore the profile of Maria C Albareda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Albareda M, De Rissio A, Tomas G, Serjan A, Alvarez M, Viotti R, et al.
PLoS Negl Trop Dis
. 2013 Dec;
7(12):e2575.
PMID: 24349591
Background: Adults with chronic Trypanosoma cruzi exhibit a poorly functional T cell compartment, characterized by monofunctional (IFN-γ-only secreting) parasite-specific T cells and increased levels of terminally differentiated T cells. It...
12.
Perez-Mazliah D, Albareda M, Alvarez M, Lococo B, Bertocchi G, Petti M, et al.
Front Immunol
. 2012 Oct;
3:295.
PMID: 23049532
Allopurinol is the most popular commercially available xanthine oxidase inhibitor and it is widely used for treatment of symptomatic hyperuricaemia, or gout. Although, several anti-inflammatory actions of allopurinol have been...
13.
Arguello R, Albareda M, Alvarez M, Bertocchi G, Armenti A, Vigliano C, et al.
PLoS One
. 2012 May;
7(5):e35966.
PMID: 22574131
We had formerly demonstrated that subjects chronically infected with Trypanosoma cruzi show impaired T cell responses closely linked with a process of T cell exhaustion. Recently, the expression of several...
14.
Olivera G, Albareda M, Alvarez M, De Rissio A, Fichera L, Cooley G, et al.
Microbes Infect
. 2010 Feb;
12(5):359-63.
PMID: 20123034
Trypanosoma cruzi-specific immune responses were evaluated in a total of 88 subjects living in areas endemic of Chagas disease of Argentina by IFN-gamma ELISPOT assays and immunoblotting. Positive T. cruzi...
15.
Laucella S, Mazliah D, Bertocchi G, Alvarez M, Cooley G, Viotti R, et al.
Clin Infect Dis
. 2009 Nov;
49(11):1675-84.
PMID: 19877967
Background: As many as 20 million people are living with Trypanosoma cruzi infection in Latin American, yet few receive any treatment. The major limitation in developing and evaluating potential new...
16.
Alvarez M, Postan M, Weatherly D, Albareda M, Sidney J, Sette A, et al.
PLoS Negl Trop Dis
. 2008 Oct;
2(9):e288.
PMID: 18846233
Background: Previously, we identified a set of HLA-A020.1-restricted trans-sialidase peptides as targets of CD8+ T cell responses in HLA-A0201+ individuals chronically infected by T. cruzi. Methods And Findings: Herein, we...
17.
Gruszynski A, van Deursen F, Albareda M, Best A, Chaudhary K, Cliffe L, et al.
Mol Biochem Parasitol
. 2006 Mar;
147(2):211-23.
PMID: 16564583
African trypanosomes (Trypanosoma brucei) have a digenetic lifecycle that alternates between the mammalian bloodstream and the tsetse fly vector. In the bloodstream, replicating long slender parasites transform into non-dividing short...
18.
Laucella S, Postan M, Martin D, Hubby Fralish B, Albareda M, Alvarez M, et al.
J Infect Dis
. 2004 Feb;
189(5):909-18.
PMID: 14976609
This study sought to quantify CD8(+) T cell responses to Trypanosoma cruzi and to identify potential links between these responses and the severity of disease in humans. In the majority...